• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Sprouty-related, EVH1 domain-containing protein 2 (SPRED2)

ACP15372

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP15372 Target NameSPRED2
Target SynonymsSPRED2; Sprouty-related; EVH1 domain-containing protein 2; Spred-2FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-418
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ7Z698
Background Information
  • Uniprot Id

    Q7Z698

  • Target Species

    Human

  • Target Name

    SPRED2

  • Target Full Name

    Sprouty-related, EVH1 domain-containing protein 2

  • Target Function

    Negatively regulates Ras signaling pathways and downstream activation of MAP kinases. Inhibits fibroblast growth factor (FGF)-induced retinal lens fiber differentiation, probably by inhibiting FGF-mediated phosphorylation of ERK1/2. Inhibits TGFB-induced epithelial-to-mesenchymal transition in lens epithelial cells.

  • Target Subcellular Location

    Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasmic vesicle, secretory vesicle membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasm.

  • Target Tissue Specificity

    Expressed in liver, skin, small intestine, salivary gland and prostate.

  • Target Synonyms

    SPRED2; Sprouty-related; EVH1 domain-containing protein 2; Spred-2

Inquire Recombinant Human Sprouty-related, EVH1 domain-containing protein 2 (SPRED2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification